What is Conformis, Inc. (CFMS)?

Conformis, Inc. (CFMS) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of CFMS?

The current price of CFMS is $2.27. Prices are updated in real time on Stocks360.

What is CFMS's price-to-earnings (PE) ratio?

CFMS's trailing twelve-month PE ratio is -0.32, based on current price and earnings per share data available on Stocks360.

What is CFMS's market capitalization?

CFMS's market capitalization is $17,881,902.00, placing it in the small-cap tier.

Conformis, Inc. (CFMS)

Stock analysis · NASDAQ · Healthcare · Medical - Devices

$2.27

Market Cap

$17.88M

PE (TTM)

-0.32

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.42

Day Range

$2.25 – $2.27

52-wk Range

$1.05 – $7.25

Avg Volume

N/A

Volume

7.08K

Conformis, Inc. (CFMS) is a publicly traded company in the Healthcare sector. Latest price: $2.27. Market cap $17.88M. Trailing PE -0.32. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 6 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

Earnings

Most Recent

Aug 2, 2023

EPS $1.78 vs est. $1.32

Beat by $0.46

Proprietary Signals

Signal snapshot temporarily unavailable.

About Conformis, Inc.

Conformis, Inc., established in Billerica, Massachusetts in 2004, functions as a medical technology enterprise that designs, produces, and commercializes custom-fit medical devices and surgical instruments. Their product portfolio encompasses a variety of personalized knee replacement systems, including iUni and iDuo for addressing unicompartmental or bicompartmental knee osteoarthritis, the iTotal CR for cruciate-retaining total knee procedures, the iTotal PS for posterior-stabilized total knee replacements, as well as the iTotal Identity and Identity Imprint lines. Additionally, the company offers hip replacement options like the Conformis Hip System and Cordera products, and provides iJigs, which are personalized, single-use surgical guides. Conformis distributes these specialized solutions to orthopedic surgeons, hospitals, and other medical facilities through its dedicated sales force, independent representatives, and distributors, serving markets across the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, Oman, Italy, Poland, and other globa…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.32×
P/S (TTM)	0.29×
P/B	0.30×
P/FCF (TTM)	-0.34×
EV / EBITDA	0.07×
EV / Sales	-0.05×
Earnings Yield	-307.99%
Free Cash Flow Yield	-291.19%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	-$3.29M
Net Income (TTM)	-$55.07M
Free Cash Flow (TTM)	-$50.05M
Net Debt	-$21.17M
Working Capital	$65.20M
Gross Margin	37.41%
Operating Margin	-74.58%
Net Margin	-81.34%
Return on Equity	-65.24%
Return on Invested Capital	-56.47%